COVID-19 rapid guideline (updated): managing symptoms (including at the end of life) in the community (NG163)

The guideline has been updated to include a link to support off-label prescribing for patients with breathlessness. Some tables were amended to highlight doses of medicines used for breathlessness, anxiety and delirium may need to be adjusted in some patients.


National Institute for Health and Care Excellence